Jorge Carrillo
Overview
Explore the profile of Jorge Carrillo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
2333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Pradenas E, Marfil S, Urrea V, Trigueros M, Pidkova T, Pons-Grifols A, et al.
iScience
. 2023 Mar;
26(4):106457.
PMID: 36999095
The elicitation of cross-variant neutralizing antibodies against SARS-CoV-2 represents a major goal for current COVID-19 vaccine strategies. Additionally, natural infection may also contribute to broaden neutralizing responses. To assess the...
22.
Moron-Lopez S, Riveira-Munoz E, Urrea V, Gutierrez-Chamorro L, Avila-Nieto C, Noguera-Julian M, et al.
Microbiol Spectr
. 2023 Mar;
:e0415922.
PMID: 36943067
Most individuals acutely infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit mild symptoms. However, 10 to 20% of those infected develop long-term symptoms, referred to as post-coronavirus disease...
23.
Aguilar-Gurrieri C, Barajas A, Rovirosa C, Ortiz R, Urrea V, de la Iglesia N, et al.
Cancer Immunol Immunother
. 2023 Feb;
72(7):2113-2125.
PMID: 36820900
Neoantigens are tumor-specific antigens that are mostly particular for each patient. Since the immune system is able to mount a specific immune response against these neoantigens, they are a promising...
24.
Smith E, Oakley E, Grandner G, Ferguson K, Farooq F, Afshar Y, et al.
BMJ Glob Health
. 2023 Jan;
8(1).
PMID: 36646475
Introduction: Despite a growing body of research on the risks of SARS-CoV-2 infection during pregnancy, there is continued controversy given heterogeneity in the quality and design of published studies. Methods:...
25.
Usai C, Pailler-Garcia L, Lorca-Oro C, Fernandez-Bastit L, Roca N, Brustolin M, et al.
Front Microbiol
. 2022 Dec;
13:1016201.
PMID: 36458182
Rodents are widely used for the development of COVID-19-like animal models, the virological outcome being determined through several laboratory methods reported in the literature. Our objective was to assess the...
26.
Bracke C, Miranda C, Gonzalez S, Casas I, Cardona P, Benitez R, et al.
Pathogens
. 2022 Nov;
11(11).
PMID: 36422615
Background: Prophylactic vaccination has proven to be the most effective strategy to fight the COVID-19 pandemic. Methods: This was a prospective observational cohort study involving 30 predominantly antibody deficiency disorders...
27.
Ainsua-Enrich E, Pedreno-Lopez N, Bracke C, Avila-Nieto C, Rodriguez de la Concepcion M, Pradenas E, et al.
iScience
. 2022 Nov;
25(11):105455.
PMID: 36320330
Mass vaccination campaigns reduced COVID-19 incidence and severity. Here, we evaluated the immune responses developed in SARS-CoV-2-uninfected patients with predominantly antibody-deficiencies (PAD) after three mRNA-1273 vaccine doses. PAD patients were...
28.
Benet S, Blanch-Lombarte O, Ainsua-Enrich E, Pedreno-Lopez N, Munoz-Basagoiti J, Raich-Regue D, et al.
J Infect Dis
. 2022 Oct;
226(11):1913-1923.
PMID: 36200261
Background: We analyzed humoral and cellular immune responses induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines in people with human immunodeficiency virus (HIV; PWH) who...
29.
Fernandez-Bastit L, Marfil S, Pradenas E, Valle R, Roca N, Rodon J, et al.
Transbound Emerg Dis
. 2022 Sep;
69(6):3518-3529.
PMID: 36167932
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic in humans, is able to infect several domestic, captive and wildlife animal species....
30.
Fernandez-Bastit L, Roca N, Romero-Durana M, Rodon J, Cantero G, Garcia O, et al.
Viruses
. 2022 Sep;
14(9).
PMID: 36146808
A wide range of animal species are susceptible to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Natural and/or experimental infections have been reported in pet, zoo, farmed and...